These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24512124)

  • 1. Comorbidity burden and guideline-concordant care for breast cancer.
    Kimmick G; Fleming ST; Sabatino SA; Wu XC; Hwang W; Wilson JF; Lund MJ; Cress R; Anderson RT;
    J Am Geriatr Soc; 2014 Mar; 62(3):482-8. PubMed ID: 24512124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of diabetes severity on receipt of guideline-concordant treatment for breast cancer.
    Sabatino SA; Thompson TD; Wu XC; Fleming ST; Kimmick GG; Trentham-Dietz A; Cress R; Anderson RT
    Breast Cancer Res Treat; 2014 Jul; 146(1):199-209. PubMed ID: 24899083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Diabetes and Other Clinical and Sociodemographic Factors With Guideline-concordant Breast Cancer Treatment for Breast Cancer.
    Gold HT; Shao H; Oratz R; Yu O; Hammer M; Richardson S; Boudreau D
    Am J Clin Oncol; 2020 Feb; 43(2):101-106. PubMed ID: 31850918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guideline-Concordant Treatment Among Elderly Women With HER2-Positive Metastatic Breast Cancer in the United States.
    Vyas AM; Aroke H; Kogut S
    J Natl Compr Canc Netw; 2020 Apr; 18(4):405-413. PubMed ID: 32259787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Impact of 21-Gene Recurrence Score Test Within the Veterans Health Administration: Utilization and Receipt of Guideline-Concordant Care.
    Hull LE; Lynch JA; Berse BB; DuVall SL; Chun DS; Venne VL; Efimova OV; Icardi MS; Kelley MJ
    Clin Breast Cancer; 2018 Apr; 18(2):135-143. PubMed ID: 29306660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older.
    Yancik R; Wesley MN; Ries LA; Havlik RJ; Edwards BK; Yates JW
    JAMA; 2001 Feb; 285(7):885-92. PubMed ID: 11180731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individual, Area, and Provider Characteristics Associated With Care Received for Stages I to III Breast Cancer in a Multistate Region of Appalachia.
    Kimmick GG; Camacho F; Mackley HB; Kern T; Yao N; Matthews SA; Fleming S; Lipscomb J; Liao J; Hwang W; Anderson RT
    J Oncol Pract; 2015 Jan; 11(1):e9-e18. PubMed ID: 25228530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of cancer death by comorbidity severity and use of adjuvant chemotherapy among women with locoregional breast cancer.
    Kimmick GG; Li X; Fleming ST; Sabatino SA; Wilson JF; Lipscomb J; Cress R; Bergom C; Anderson RT; Wu XC;
    J Geriatr Oncol; 2018 May; 9(3):214-220. PubMed ID: 29174187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of Age on Guideline-Concordant Cancer Care for Elderly Patients in the United States.
    Fang P; He W; Gomez DR; Hoffman KE; Smith BD; Giordano SH; Jagsi R; Smith GL
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):748-757. PubMed ID: 28366580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers.
    Wu XC; Lund MJ; Kimmick GG; Richardson LC; Sabatino SA; Chen VW; Fleming ST; Morris CR; Huang B; Trentham-Dietz A; Lipscomb J
    J Clin Oncol; 2012 Jan; 30(2):142-50. PubMed ID: 22147735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of locoregional treatment for nonmetastatic breast cancer by patient and health system factors.
    Anderson RT; Morris CR; Kimmick G; Trentham-Dietz A; Camacho F; Wu XC; Sabatino SA; Fleming ST; Lipscomb J
    Cancer; 2015 Mar; 121(5):790-9. PubMed ID: 25369150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receipt of Guideline-Concordant Care Among Older Women With Stage I-III Breast Cancer: A Population-Based Study.
    LeMasters T; Madhavan SS; Sambamoorthi U; Hazard-Jenkins HW; Kelly KM; Long D
    J Natl Compr Canc Netw; 2018 Jun; 16(6):703-710. PubMed ID: 29891521
    [No Abstract]   [Full Text] [Related]  

  • 13. Guideline-concordant lung cancer care and associated health outcomes among elderly patients in the United States.
    Nadpara PA; Madhavan SS; Tworek C; Sambamoorthi U; Hendryx M; Almubarak M
    J Geriatr Oncol; 2015 Mar; 6(2):101-10. PubMed ID: 25604094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receipt of guideline-concordant treatment in elderly prostate cancer patients.
    Chen RC; Carpenter WR; Hendrix LH; Bainbridge J; Wang AZ; Nielsen ME; Godley PA
    Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):332-8. PubMed ID: 24411605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Guideline-Discordant Treatment on Cost and Health Care Utilization in Older Adults with Early-Stage Breast Cancer.
    Williams CP; Kenzik KM; Azuero A; Williams GR; Pisu M; Halilova KI; Ingram SA; Yagnik SK; Forero A; Bhatia S; Rocque GB
    Oncologist; 2019 Jan; 24(1):31-37. PubMed ID: 30120157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population-Based Study on Cancer Subtypes, Guideline-Concordant Adjuvant Therapy, and Survival Among Women With Stage I-III Breast Cancer.
    Hsieh MC; Zhang L; Wu XC; Davidson MB; Loch M; Chen VW
    J Natl Compr Canc Netw; 2019 Jun; 17(6):676-686. PubMed ID: 31200362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concordance with NCCN treatment guidelines: Relations with health care utilization, cost, and mortality in breast cancer patients with secondary metastasis.
    Rocque GB; Williams CP; Kenzik KM; Jackson BE; Azuero A; Halilova KI; Ingram SA; Pisu M; Forero A; Bhatia S
    Cancer; 2018 Nov; 124(21):4231-4240. PubMed ID: 30317547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Nonconcordance With NCCN Guidelines on Resource Utilization, Cost, and Mortality in De Novo Metastatic Breast Cancer.
    Rocque GB; Williams CP; Jackson BE; Ingram SA; Halilova KI; Pisu M; Kenzik KM; Azuero A; Forero A; Bhatia S
    J Natl Compr Canc Netw; 2018 Sep; 16(9):1084-1091. PubMed ID: 30181420
    [No Abstract]   [Full Text] [Related]  

  • 19. Severity of comorbid conditions and early-stage breast cancer therapy: linked SEER-Medicare data from 1993 to 2005.
    Yasmeen S; Chlebowski RT; Xing G; Morris CR; Romano PS
    Cancer Med; 2013 Aug; 2(4):526-36. PubMed ID: 24156025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors Associated With Guideline-Concordant Pharmacological Treatment for Neuropathic Pain Among Breast Cancer Survivors.
    Lakkad M; Martin B; Li C; Harrington S; Dayer L; Painter JT
    Clin Breast Cancer; 2023 Aug; 23(6):598-619. PubMed ID: 37328334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.